Pharma Industry News
Printable Version   Email to a friend

Antibiotic Rx: No Substitute for Time Spent with Patient

October 14, 2005

Gone are the days when a visit to your doctor included a lengthy chat. Visits are often as short as possible, with doctors wanting to maximize their patient numbers and thus their incomes. But does replacing doctor-patient discussion time with a hastily written prescription affect patient satisfaction?

It does, according to Researchers at the Centers for Disease Control, who recently found that patients who received an antibiotic prescription for acute respiratory tract infection (URI) found it to be "an unsatisfactory substitute for spending time with the patient, explaining the condition and treatment."

The study data were presented at the Infectious Disease Society of America Meeting 2005 and reported by MedPage Today on 12 October.

Results of Data Review

To test the notion people with URIs require a prescription to feel adequately cared for, Alexandra Newman, DVM, MPH, and colleagues at the CDC reviewed pharmacy records and corresponding patient-satisfaction surveys from a clinic's in-house pharmacy, according to MedPage Today.

Newman and colleagues reviewed a total of 1,404 surveys sent out by the Marshfield Clinic (a regional HMO in Marshfield, Wisconsin) between 1999 and 2003. All patients whose records were included in the study had sought care from a primary-care doctor to treat a URI, according to the CDC team. Among the patient group studied, 217 adults (45% of 486) and 408 children (49% of 918) received antibiotics. Nearly half (46%) the adults and one-third (31%) of the children received non-bacterial diagnoses.

A review of data revealed no correlation between treatment satisfaction and receiving an antibiotic prescription among either parents of children who received treatment or the adults who received treatment. Additionally, the likelihood of participants in either group giving their treatment an "excellent" rating in the survey did not increase with receipt of an antibiotic prescription.

In contrast, the physicians' spending time with the patient and explaining what he/she thought was going on and what they planned to do about it, as well as the physician's personal manner, were positively associated with an "excellent" rating among both groups.

Dr. Newman noted that the surveys' low response rate (31%) may have introduced a selection bias in the study sample, and added, "We have to work with the tools available," according to MedPage Today.

Moreover, cross-checking the pharmacy data with chart information revealed that a significant number of antibiotic prescriptions were not captured in the original analysis. These prescriptions may have been filled outside the HMO system, may not have been filled at all, or the patients may have received samples, according to the study researchers.

Sources:
IDSA: A Scribbled Antibiotic Prescription Can't Buy Patient Satisfaction, MedPage Today, 12 October 2005.
Newman, A. Patient Satisfaction and Antibiotic Use for Acute Upper Respiratory Tract Infections, Infectious Disease Society of America Meeting 2005, Abstract #124.

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


MedNotes
Latest FDA Drug Alerts
August 14, 2008
Audience: Cardiologists, hospital risk managers [Posted 08/14/2008] Boston Scientific and FDA informed healthcare professionals...
August 12, 2008
Audience: Primary healthcare physicians, internists, other healthcare professionals[Posted 08/12/2008] FDA informed healthcare...
August 12, 2008
Audience: Pain management specialists, risk managers, other healthcare professionals, patients[UPDATED 08/12/2008] Watson...
August 8, 2008
Audience: Oncologists, other healthcare professionals[Posted 07/31/2008] FDA informed healthcare professionals of modifications...
More...
Latest Drug Information Updates

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

Navstel
Navstel is a balanced salt ophthalmic solution for use as an intraocular irrigation during surgical procedures involving perfusion of the eye.

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

More...